問卷

TPIDB > Principal Investigator

Principal Investigator


Linkou Chang Gung Medical Foundation

Division of Neurology

更新時間:2023-09-19

林宜穎
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

2Cases

2025-10-15 - 2032-12-31

Phase III

Active
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early-Stage Parkinson's Disease
  • Condition/Disease

    Parkinson's Disease

  • Test Drug

    Injectable

Participate Sites
6Sites

Recruiting6Sites

2023-05-01 - 2027-06-24

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
12Sites

Recruiting12Sites